CVE-2025-61940

Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication

State: Published
Severity: 8.7 High
Published: Dec 2, 2025
Updated: Dec 9, 2025
Reserved: Nov 11, 2025

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

Scores

CVSS	Score	Vector	Source
4.0	8.7 High	CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N	icscert
3.1	8.3 High	CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L	icscert

Weaknesses

CWE-603

Affected Products

Product	Versions
EC2 Software NMIS BioDoseMirion Medical	before 23.0Affected 23.0Not affected

References

https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01

Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.